News for Haematology and Stem Cells
Researchers map leukaemia ‘family trees’ in patients treated with new drug
A team of international researchers, including experts from NIHR Oxford BRC, has for the first time mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains what happens when a patient stops responding to the treatment, providing … Read more
New haematology patient group launched
The launch of a new patient engagement group for those with blood conditions has brought together patients, clinicians and researchers to discuss how to get patient involved in research. A screening of the film People are Messy at the Ultimate Picture Palace followed by a group discussion marked the launch of the Oxford Blood Group, a new local … Read more
Oxford Centre for Haematology stages inaugural event
The new Oxford Centre for Haematology has held its inaugural event at Keble College, Oxford. The event, which will be held annually, was attended by around 200 academics, healthcare professionals and representatives of industry. Some speakers travelled from as far away as the United States. The event was opened by Prof Paresh Vyas, Director of … Read more
Oxford medical researchers win prestigious national awards
Leading health researchers in Oxford have been recognised in a prestigious national competition. Eight professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre … Read more
Oxford Centre for Haematology launched
The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxford University Hospitals NHS Foundation Trust. The aim of this new virtual centre is to bring people working in haematology together to improve the understanding and treatment … Read more
MDS Patient Support Group learn more about treatment of condition
Patients and relatives affected by Myelodysplastic Syndromes (MDS) have visited the MRC Weatherall Institute of Molecular Medicine (WIMM) at the John Radcliffe Hospital to find out more about advances in treating the condition. The members of the Oxford and Thames Valley MDS Patient Support Group visited the WIMM Friday 29 September. MDS are a group … Read more
Researchers thank Bloodwise fundraisers for funding critical leukaemia trial
Staff and patients at the Oxford Cancer Centre at the Churchill Hospital have thanked fundraisers for the Bloodwise charity who have raised enough money to fully fund a trial of a new leukaemia drug. The staff and patient Thelma, who has been on the trial, sent their appreciation in a video to Bloodwise after fundraisers, … Read more
New drug gives hope in fight against leukaemia
An international group of haematology scientists, including leading researchers in Oxford, have secured approval from the US Food and drug Administration (FDA) for a new leukaemia drug that has produced exciting results in clinical trials. The development of Enasidenib has given hope to people with a form of acute myeloid leukaemia (AML), one of the … Read more
New clinical trial to tackle hard-to-treat leukaemia
A new clinical trial at Oxford’s Churchill Hospital plans to study the safety of a new experimental drug to treat a form of leukaemia, called Acute Myeloid Leukaemia (AML). Acute myeloid leukaemia is the most common aggressive blood cancer and there are about 2,200 new cases in the UK each year. It can be hard … Read more